sk&f 82958 and 4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide

sk&f 82958 has been researched along with 4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, C; Dimattio, K; Li, JG; Liu-Chen, LY; Unterwald, E; Wang, Y; Xu, W1

Other Studies

1 other study(ies) available for sk&f 82958 and 4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide

ArticleYear
PKA and ERK1/2 are involved in dopamine D₁ receptor-induced heterologous desensitization of the δ opioid receptor.
    Life sciences, 2013, Jun-21, Volume: 92, Issue:23

    Topics: Animals; Benzamides; Benzazepines; Blotting, Western; Cell Line; CHO Cells; Cocaine; Cricetinae; Cyclic AMP-Dependent Protein Kinases; Down-Regulation; MAP Kinase Signaling System; Mice; Phosphorylation; Piperazines; Rats; Receptors, Dopamine D1; Receptors, Opioid, delta

2013